Trial Profile
Clinical Trials Insight: 700060229
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 14 Oct 2010
Price :
$35
*
At a glance
- Drugs Pralatrexate (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 14 Oct 2010 New trial record